HB5631 Summary: Blood Clotting Products

• Amends the Pharmacy Practice Act by adding Section 26.5 to establish requirements for pharmacies dispensing blood clotting products to bleeding disorder patients.

• Requires prescriptions for blood clotting products be dispensed as written without substitution unless prescriber-authorized, with patient notification and counseling prior to any changes.

• Mandates pharmacies ship blood clotting products to established patients within 2 business days and new patients within 3 business days of receiving requests, with proper cold chain management.

• Requires pharmacies dispensing blood clotting products to establish 24/7 pharmacist availability, maintain supplier arrangements for all FDA-approved products, complete 4 continuing education hours annually, and register with National Patient Notification System for recall alerts.

• Establishes written policies and procedures for pharmacies regarding prescription processing, recall notifications, emergency dispensing, patient termination notice (7 days minimum), and insurance preauthorization communication.